2-148489398-G-T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001378120.1(MBD5):c.3766G>T(p.Glu1256*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. E1256E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001378120.1 stop_gained
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- intellectual disability, autosomal dominant 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001378120.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MBD5 | NM_001378120.1 | MANE Select | c.3766G>T | p.Glu1256* | stop_gained | Exon 11 of 14 | NP_001365049.1 | ||
| MBD5 | NM_001438854.1 | c.3766G>T | p.Glu1256* | stop_gained | Exon 12 of 15 | NP_001425783.1 | |||
| MBD5 | NM_001438856.1 | c.3766G>T | p.Glu1256* | stop_gained | Exon 12 of 15 | NP_001425785.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MBD5 | ENST00000642680.2 | MANE Select | c.3766G>T | p.Glu1256* | stop_gained | Exon 11 of 14 | ENSP00000493871.2 | ||
| MBD5 | ENST00000407073.5 | TSL:1 | c.3067G>T | p.Glu1023* | stop_gained | Exon 12 of 15 | ENSP00000386049.1 | ||
| MBD5 | ENST00000638043.2 | TSL:5 | c.3067G>T | p.Glu1023* | stop_gained | Exon 11 of 14 | ENSP00000490728.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
An E1023X variant that is likely pathogenic has been identified in the MBD5 gene. The E1023X variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The E1023X variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The E1023X nonsense variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at